MarkDouglasCunninghamDO

PubMed

• 122 citations
  Autoimmune pathways in mice and humans are blocked by pharmacological stabilization of the TYK2 pseudokinase domain.
  James R. Burke, Lihong Cheng, Kathleen M. Gillooly, Joann Strnad, Adriana Zupa-Fernandez, Ian M. Catlett, Yifan Zhang, Elizabeth M. Heimrich, Kim W. McIntyre, Mark D. ...> ;Science Translational Medicine. 2019 Jul 24
• 82 citations
  Circulating T Cell Subpopulations Correlate With Immune Responses at the Tumor Site and Clinical Response to PD1 Inhibition in Non-Small Cell Lung Cancer.
  Nataly Manjarrez-Orduño, Laurence Menard, Selena Kansal, Paul Fischer, Bijal Kakrecha, Can Jiang, Mark D. Cunningham, Danielle Greenawalt, Vishal Patel, Minghui Yang, ...> ;Frontiers in Immunology. 2018 Aug 3
• 35 citations
  B cells from African American lupus patients exhibit an activated phenotype
  Laurence Menard, Sium Habte, Waldemar Gonsiorek, Deborah Lee, Dana Banas, Deborah A. Holloway, Nataly Manjarrez-Orduño, Mark D. Cunningham, Dawn K. Stetsko, Francesca ...> ;JCI Insight. 2016 Jun 16
• 9 citations
  Improving the pharmacokinetic and CYP inhibition profiles of azaxanthene-based glucocorticoid receptor modulators-identification of (S)-5-(2-(9-fluoro-2-(4-(2-hydroxyp...
  Michael G. Yang, T.G. Dhar, Zili Xiao, Hai-Yun Xiao, Jingwu Duan, Bin Jiang, Michael Galella, Mark D. Cunningham, Jinhong Wang, Sium Habte, David J. Shuster, Kim W. Mc...> ;Journal of Medicinal Chemistry. 2015 May 7
• 5 citations
  Discovery of acylurea isosteres of 2-acylaminothiadiazole in the azaxanthene series of glucocorticoid receptor agonists.
  Hua Gong, Michael Yang, Zili Xiao, Arthur M. Doweyko, Mark D. Cunningham, Jinhong Wang, Sium Habte, Deborah A. Holloway, Christine Burke, David J. Shuster, Ling Gao, J...> ;Bioorganic & Medicinal Chemistry Letters. 2014 Aug 1
• 5 citations
  Heterocyclic glucocorticoid receptor modulators with a 2,2-dimethyl-3-phenyl-N-(thiazol or thiadiazol-2-yl)propanamide core.
  Hai-Yun Xiao, Dauh-Rurng Wu, James E. Sheppeck, Sium Habte, Mark D. Cunningham, John E. Somerville, Joel C. Barrish, Steven G. Nadler, T. G. Murali Dhar> ;Bioorganic & Medicinal Chemistry Letters. 2013 Oct 15
• 8 citations
  Synthesis and structure-activity relationships of novel indazolyl glucocorticoid receptor partial agonists.
  John L. Gilmore, James E. Sheppeck, Jim Wang, T. G. Murali Dhar, Cullen L. Cavallaro, Arthur M. Doweyko, Lorraine I. McKay, Mark D. Cunningham, Sium Habte, Steven G. N...> ;Bioorganic & Medicinal Chemistry Letters. 2013 Oct 1
• 11 citations
  Discovery of potent and selective nonsteroidal indazolyl amide glucocorticoid receptor agonists
  James E. Sheppeck, John L. Gilmore, Hai Yun Xiao, T. G. Murali Dhar, David S. Nirschl, Arthur M. Doweyko, Jack S. Sack, Martin J. Corbett, Mary F. Malley, Jack Z. Goug...> ;Bioorganic & Medicinal Chemistry Letters. 2013 Oct 1
• 1 citations
  Probability of criminal acts of violence: a test of jury predictive accuracy.
  Thomas J. Reidy, Jon R. Sorensen, Mark D. Cunningham> ;Behavioral Sciences & the Law. 2013 Mar 1
• 5 citations
  Community violence to prison assault: a test of the behavioral continuity hypothesis.
  Thomas J. Reidy, Jon R. Sorensen, Mark D. Cunningham> ;Law and Human Behavior. 2012 Aug 1
• 28 citations
  Azaxanthene based selective glucocorticoid receptor modulators: design, synthesis, and pharmacological evaluation of (S)-4-(5-(1-((1,3,4-thiadiazol-2-yl)amino)-2-methy...
  David S. Weinstein, Hua Gong, Arthur M. Doweyko, Mark D. Cunningham, Sium Habte, Jin Hong Wang, Deborah A. Holloway, Christine Burke, Ling Gao, Victor R. Guarino, Juli...> ;Journal of Medicinal Chemistry. 2011 Oct 3
• Structure-based design of new DHFR-based antibacterial agents: 7-aryl-2,4-diaminoquinazolines.
  Li X, Hilgers M, Cunningham M, Chen Z, Trzoss M, Zhang J, Kohnen L, Lam T, Creighton C, G C K, Nelson K, Kwan B, Stidham M, Brown-Driver V, Shaw KJ, Finn J> ;Bioorg. Med. Chem. Lett.. 2011-09-15
• 4 citations
  Life and death in the lone star state: Three decades of violence predictions by capital juries
  Mark D. Cunningham, Jon R. Sorensen, Mark P. Vigen, S.O. Woods> ;Behavioral Sciences & the Law. 2011 Jan 1
• 19 citations
  Dimethyl-diphenyl-propanamide derivatives as nonsteroidal dissociated glucocorticoid receptor agonists.
  Bingwei V. Yang, David S. Weinstein, Lidia M. Doweyko, Hua Gong, Wayne Vaccaro, Tram N. Huynh, Hai Yun Xiao, Arthur M. Doweyko, Lorraine I. McKay, Deborah A. Holloway,...> ;Journal of Medicinal Chemistry. 2010 Nov 12
• 2 citations
  Improbable Predictions at Capital Sentencing: Contrasting Prison Violence Outcomes
  Mark D. Cunningham, Jon R. Sorensen> ;The Journal of the American Academy of Psychiatry and the Law. 2010 Mar 1
• 20 citations
  Novel Synthesis of the Hexahydroimidazo[1,5b]isoquinoline Scaffold: Application to the Synthesis of Glucocorticoid Receptor Modulators†
  Hai Yun Xiao, Dauh Rurng Wu, Mary F. Malley, Jack Z. Gougoutas, Sium Habte, Mark D. Cunningham, John E. Somerville, John H. Dodd, Joel C. Barrish, Steven G. Nadler, T....> ;Journal of Medicinal Chemistry. 2010 Jan 4
• 15 citations
  Assertions of “Future Dangerousness” at Federal Capital Sentencing: Rates and Correlates of Subsequent Prison Misconduct and Violence
  Mark D. Cunningham, Thomas J. Reidy, Jon R. Sorensen> ;Law and Human Behavior. 2008 Feb 1
• 10 citations
  Capital Offenders in Texas Prisons: Rates, Correlates, and an Actuarial Analysis of Violent Misconduct
  Mark D. Cunningham, Jon R. Sorensen> ;Law and Human Behavior. 2007 Mar 23
• 9 citations
  Dangerousness and death: a nexus in search of science and reason
  Mark D. Cunningham> ;The American Psychologist. 2006 Nov 1
• 17 citations
  Actuarial models for assessing prison violence risk: revisions and extensions of the Risk Assessment Scale for Prison (RASP).
  Mark D. Cunningham, Jon R. Sorensen> ;Assessment. 2006 Sep 1
• 10 citations
  Is death row obsolete? A decade of mainstreaming death-sentenced inmates in Missouri.
  Mark D. Cunningham, Thomas J. Reidy, Jon R. Sorensen> ;Behavioral Sciences & the Law. 2005 May 1
• 26 citations
  An actuarial model for assessment of prison violence risk among maximum security inmates.
  Mark D. Cunningham, Jon R. Sorensen, Thomas J. Reidy> ;Assessment. 2005 Mar 1
• Toll-like receptor 9 can be expressed at the cell surface of distinct populations of tonsils and human peripheral blood mononuclear cells.
  Eaton-Bassiri A, Dillon SB, Cunningham M, Rycyzyn MA, Mills J, Sarisky RT, Mbow ML> ;Infect. Immun.. 2004-12-01
• 19 citations
  An intracellular targeted NLS peptide inhibitor of karyopherin α:NF-κB interactions
  Mark D. Cunningham, Jeffrey S. Cleaveland, Steven G. Nadler> ;Biochemical and Biophysical Research Communications. 2003 Jan 10
• 19 citations
  Death row inmate characteristics, adjustment, and confinement: a critical review of the literature
  Mark D. Cunningham, Mark P. Vigen> ;Behavioral Sciences & the Law. 2002 Jan 1
• Join now to see all